| Year |
Citation |
Score |
| 2022 |
Panayi MC, Boerner T, Jahans-Price T, Huber A, Sprengel R, Gilmour G, Sanderson DJ, Harrison PJ, Walton ME, Bannerman DM. Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience. Molecular Psychiatry. PMID 36460723 DOI: 10.1038/s41380-022-01861-8 |
0.725 |
|
| 2021 |
Korn C, Akam T, Jensen KHR, Vagnoni C, Huber A, Tunbridge EM, Walton ME. Distinct roles for dopamine clearance mechanisms in regulating behavioral flexibility. Molecular Psychiatry. PMID 34193974 DOI: 10.1038/s41380-021-01194-y |
0.442 |
|
| 2014 |
McHugh SB, Barkus C, Huber A, Capitão L, Lima J, Lowry JP, Bannerman DM. Aversive prediction error signals in the amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9024-33. PMID 24990922 DOI: 10.1523/Jneurosci.4465-13.2014 |
0.305 |
|
| 2014 |
Barkus C, Line SJ, Huber A, Capitao L, Lima J, Jennings K, Lowry J, Sharp T, Bannerman DM, McHugh SB. Variation in serotonin transporter expression modulates fear-evoked hemodynamic responses and theta-frequency neuronal oscillations in the amygdala. Biological Psychiatry. 75: 901-8. PMID 24120093 DOI: 10.1016/J.Biopsych.2013.09.003 |
0.333 |
|
| 2013 |
Baudonnat M, Huber A, David V, Walton ME. Heads for learning, tails for memory: reward, reinforcement and a role of dopamine in determining behavioral relevance across multiple timescales. Frontiers in Neuroscience. 7: 175. PMID 24130514 DOI: 10.3389/Fnins.2013.00175 |
0.726 |
|
| 2012 |
Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton ME. The role of catechol-O-methyltransferase in reward processing and addiction. Cns & Neurological Disorders Drug Targets. 11: 306-23. PMID 22483300 DOI: 10.2174/187152712800672409 |
0.707 |
|
| 2011 |
McCabe C, Huber A, Harmer CJ, Cowen PJ. The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology. 217: 271-8. PMID 21494790 DOI: 10.1007/S00213-011-2278-4 |
0.59 |
|
| 1991 |
Shippenberg TS, Bals-Kubik R, Huber A, Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14. PMID 1827526 DOI: 10.1007/BF02244205 |
0.395 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Steinkellner H, Kempaiah P, Beribisky AV, Pferschy S, Etzler J, Huber A, Sarne V, Neuhaus W, Kuttke M, Bauer J, Arunachalam JP, Christodoulou J, Dressel R, Mildner A, Prinz M, et al. TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome. International Journal of Biological Macromolecules. 209: 972-983. PMID 35460749 DOI: 10.1016/j.ijbiomac.2022.04.080 |
0.142 |
|
| 2010 |
McCabe C, Huber A, Harmer C, Cowen P. P.1.e.019 Acute administration of the anti-psychotic sulpiride modulates the neural response to chocolate in healthy volunteers European Neuropsychopharmacology. 20: S299. DOI: 10.1016/S0924-977X(10)70398-9 |
0.129 |
|
| 2024 |
Huber A, Sarne V, Beribisky AV, Ackerbauer D, Derdak S, Madritsch S, Etzler J, Huck S, Scholze P, Gorgulu I, Christodoulou J, Studenik CR, Neuhaus W, Connor B, Laccone F, et al. Generation and characterization of a human neuronal in vitro model for Rett Syndrome using a direct reprogramming method. Stem Cells and Development. PMID 38164119 DOI: 10.1089/scd.2023.0233 |
0.12 |
|
| 2023 |
Waldman HS, O'Neal EK, Barker GA, Witt CR, Lara DA, Huber AK, Forsythe VN, Koutnik AP, D'Agostino DP, Staiano W, Egan B. A Ketone Monoester with Carbohydrate Improves Cognitive Measures Post-Exercise, but not Performance in Trained Females. Medicine and Science in Sports and Exercise. PMID 38051034 DOI: 10.1249/MSS.0000000000003352 |
0.12 |
|
| 1988 |
Shippenberg TS, Stein C, Huber A, Millan MJ, Herz A. Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists. Pain. 35: 179-86. PMID 2853321 DOI: 10.1016/0304-3959(88)90225-4 |
0.118 |
|
| 2019 |
Steinkellner H, Schönegger A, Etzler J, Kempaiah P, Huber A, Hahn K, Rose K, Duerr M, Christodoulou J, Beribisky AV, Neuhaus W, Laccone F. An electrochemiluminescence based assay for quantitative detection of endogenous and exogenously applied MeCP2 protein variants. Scientific Reports. 9: 7929. PMID 31138832 DOI: 10.1038/s41598-019-44372-3 |
0.114 |
|
| 2019 |
Huber A, Oemer G, Malanovic N, Lohner K, Kovács L, Salvenmoser W, Zschocke J, Keller MA, Marx F. Membrane Sphingolipids Regulate the Fitness and Antifungal Protein Susceptibility of . Frontiers in Microbiology. 10: 605. PMID 31031714 DOI: 10.3389/fmicb.2019.00605 |
0.101 |
|
| 2022 |
Beribisky AV, Steinkellner H, Geislberger S, Huber A, Sarne V, Christodoulou J, Laccone F. Expression, Purification, Characterization and Cellular Uptake of MeCP2 Variants. The Protein Journal. 41: 345-359. PMID 35546650 DOI: 10.1007/s10930-022-10054-9 |
0.094 |
|
| 2020 |
Steinkellner H, Beribisky AV, Mausberg P, Christodoulou J, Scheiber-Mojdehkar B, Huber A, Sarne V, Laccone F. An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants. Journal of Visualized Experiments : Jove. PMID 32510486 DOI: 10.3791/61054 |
0.093 |
|
| 2020 |
Kohlhoff J, Cibralic S, Wallace N, Morgan S, McMahon C, Hawkins E, Eapen V, Briggs N, Huber A, McNeil C. A randomized controlled trial comparing parent child interaction therapy - toddler, circle of security- parenting™ and waitlist controls in the treatment of disruptive behaviors for children aged 14-24 months: study protocol. Bmc Psychology. 8: 93. PMID 32867832 DOI: 10.1186/S40359-020-00457-7 |
0.087 |
|
| 2020 |
Begander B, Huber A, Döring M, Sperl J, Sieber V. Development of an Improved Peroxidase-Based High-Throughput Screening for the Optimization of D-Glycerate Dehydratase Activity. International Journal of Molecular Sciences. 21. PMID 31947885 DOI: 10.3390/ijms21010335 |
0.078 |
|
| 2019 |
Hajdu D, Huber A, Czajlik A, Tóth L, Kele Z, Kocsubé S, Fizil Á, Marx F, Galgóczy L, Batta G. Solution structure and novel insights into phylogeny and mode of action of the Neosartorya (Aspergillus) fischeri antifungal protein (NFAP). International Journal of Biological Macromolecules. PMID 30738898 DOI: 10.1016/J.Ijbiomac.2019.02.016 |
0.076 |
|
| 2019 |
Huber A, Lerchster H, Marx F. Nutrient Excess Triggers the Expression of the Antifungal Protein PAFB. Microorganisms. 7. PMID 31817241 DOI: 10.3390/microorganisms7120654 |
0.058 |
|
| 2012 |
Maslowski N, Huber A, Westphal D, Wittchen H, Lueken U. P.1.e.020 Neural correlates of inspiratory breathing restriction: an fMRI pilot study European Neuropsychopharmacology. 22: S203-S204. DOI: 10.1016/S0924-977X(12)70295-X |
0.056 |
|
| 2021 |
Guagnini F, Huber A, Alex JM, Marx F, Crowley PB. Porous assembly of an antifungal protein mediated by zinc and sulfonato-calix[8]arene. Journal of Structural Biology. 213: 107711. PMID 33631304 DOI: 10.1016/j.jsb.2021.107711 |
0.055 |
|
| 2018 |
Huber A, Hajdu D, Bratschun-Khan D, Gáspári Z, Varbanov M, Philippot S, Fizil Á, Czajlik A, Kele Z, Sonderegger C, Galgóczy L, Bodor A, Marx F, Batta G. New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176. Scientific Reports. 8: 1751. PMID 29379111 DOI: 10.1038/S41598-018-20002-2 |
0.045 |
|
| 2021 |
Maxwell AM, Reay RE, Huber A, Hawkins E, Woolnough E, McMahon C. Parent and practitioner perspectives on Circle of Security Parenting (COS-P): A qualitative study. Infant Mental Health Journal. PMID 33852163 DOI: 10.1002/imhj.21916 |
0.043 |
|
| 2003 |
Kingston M, Huber A, Onslow M, Jones M, Packman A. Predicting treatment time with the Lidcombe Program: replication and meta-analysis. International Journal of Language & Communication Disorders. 38: 165-77. PMID 12745935 DOI: 10.1080/1368282031000062882 |
0.042 |
|
| 2020 |
Huber A, Hicks AM, Ball M, McMahon C. Postintervention and follow-up changes in caregiving behavior and representations after individually or group delivered hybrid Circle of Security-intensive intervention with New Zealand caregiver-child dyads. Attachment & Human Development. 1-22. PMID 32799752 DOI: 10.1080/14616734.2020.1809057 |
0.038 |
|
| 2017 |
McMahon C, Huber A, Kohlhoff J, Camberis AL. DOES TRAINING IN THE CIRCLE OF SECURITY FRAMEWORK INCREASE RELATIONAL UNDERSTANDING IN INFANT/CHILD AND FAMILY WORKERS? Infant Mental Health Journal. PMID 28834602 DOI: 10.1002/imhj.21661 |
0.034 |
|
| 2020 |
Maxwell AM, McMahon C, Huber A, Hawkins E, Reay RE. Addressing the Evidence Gap: Protocol for an Effectiveness Study of Circle of Security Parenting, an Attachment-Based Intervention. Frontiers in Global Women's Health. 1: 575752. PMID 34816157 DOI: 10.3389/fgwh.2020.575752 |
0.034 |
|
| 2021 |
Angermann R, Huber AL, Nowosielski Y, Salcher S, Gasser T, Seifarth C, Kralinger MT, Zehetner C. Changes in Systemic Levels of Vascular Endothelial Growth Factor After Intravitreal Injection of Aflibercept or Brolucizumab for Neovascular Age-Related Macular Degeneration. Retina (Philadelphia, Pa.). PMID 34731094 DOI: 10.1097/IAE.0000000000003344 |
0.026 |
|
| 2021 |
Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. Journal of Ophthalmology. 2021: 7058505. PMID 34956670 DOI: 10.1155/2021/7058505 |
0.022 |
|
| 2015 |
Huber A, McMahon C, Sweller N. Improved child behavioural and emotional functioning after Circle of Security 20-week intervention. Attachment & Human Development. 17: 547-69. PMID 26422336 DOI: 10.1080/14616734.2015.1086395 |
0.019 |
|
| 2016 |
Sonderegger C, Galgóczy L, Garrigues S, Fizil Á, Borics A, Manzanares P, Hegedüs N, Huber A, Marcos JF, Batta G, Marx F. A Penicillium chrysogenum-based expression system for the production of small, cysteine-rich antifungal proteins for structural and functional analyses. Microbial Cell Factories. 15: 192. PMID 27835989 DOI: 10.1186/S12934-016-0586-4 |
0.018 |
|
| 2022 |
Ecke S, Huber A, Hilfrich R, French L, Reinholz M. Human Papillomavirus Type 16 L1 Serological Test Shows High Concordance with Anal Cytology in People Living with HIV. Jid Innovations : Skin Science From Molecules to Population Health. 2: 100124. PMID 35620706 DOI: 10.1016/j.xjidi.2022.100124 |
0.011 |
|
| 2017 |
Clark RL, Edwards TL, Longo M, Kinney J, Walker DK, Rhodes J, Clode SA, Rückle T, Wells T, Andenmatten N, Huber AC. Improved safety margin for embryotoxicity in rats for the new endoperoxide artefenomel (OZ439) as compared to artesunate. Birth Defects Research. PMID 29193867 DOI: 10.1002/bdr2.1170 |
0.011 |
|
| 2021 |
Angermann R, Huber AL, Hofer M, Nowosielski Y, Egger S, Kralinger MT, Zehetner C. Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential factors. Bmj Open. 11: e052513. PMID 34933861 DOI: 10.1136/bmjopen-2021-052513 |
0.011 |
|
| 2021 |
Angermann R, Hofer M, Huber AL, Rauchegger T, Nowosielski Y, Casazza M, Falanga V, Zehetner C. The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study. Acta Ophthalmologica. PMID 34145756 DOI: 10.1111/aos.14946 |
0.01 |
|
| 2015 |
Huber A, McMahon CA, Sweller N. EFFICACY OF THE 20-WEEK CIRCLE OF SECURITY INTERVENTION: CHANGES IN CAREGIVER REFLECTIVE FUNCTIONING, REPRESENTATIONS, AND CHILD ATTACHMENT IN AN AUSTRALIAN CLINICAL SAMPLE. Infant Mental Health Journal. PMID 26551929 DOI: 10.1002/imhj.21540 |
0.01 |
|
| Hide low-probability matches. |